Targeting Oral Squamous Cell Carcinoma with Combined Polo-Like-Kinase-1 Inhibitors and γ-Radiation TherapySubhanwita Sarkar(University of Calgary), Pinaki Bose(University of Calgary)BiomedicinesFebruary 23, 202410.3390/biomedicines12030503Cited by 4SaveCiteExport RISWatch citationsRelated PapersTumor cell apoptosis mediated by cytoplasmic ING1 is associated with improved survival in oral squamous cell carcinoma patients|Oncotarget|2014|11Polo-like kinase-1 (PLK-1) inhibitors as novel therapeutics in oral squamous cell carcinoma|Open MIND|2019|0